Program 2025
Program overview of – still under development
Precision prevention leverages individual risk assessments and tailored interventions to revolutionize preventive care. But precision in prevention also includes how to find the best preventive strategies and measures on population levels. The symposium will address critical questions at the intersection of science, clinical practice, policy, and ethics.
Monday May 5
Lunch will be served upon arrival at Engelsbergs Ironworks.
Session one: Medical and scientific aspects.
What new methods and understanding of individual risk factors are available today, and what can we expect in the future? Could prevention be tailored using genetics, biomarkers, phenotypic traits, and environmental/lifestyle factors? How are tools like omics technologies, AI, and interdisciplinary collaboration used for risk prediction and decision-making?
Coffe Break
Session 2: Health economic aspects and precision prevention in the clinic.
What can we expect in terms of cost-effectiveness for prevention compared to other treatments? When is it cost-effective to introduce different types of screening? In clinical practice, precision prevention involves using personal data to identify risk, tailor screenings and interventions. Are there good examples to learn from? How could one measure success through clinical effectiveness, cost-efficiency, and quality of life improvements?
Dinner and fireside chats
Tuesday May 6
Breakfast
Block 3: Business aspects.
What reimbursement and business models exist or must be developed for preventive measures? How does one scale successful pilots? Are there other countries or regions that have found innovative solutions for preventive care?
Coffe Break
Block 4: Political, societal, and ethical aspects of the future.
How is the responsibility divided between the individual, health-care and society when individual risks can be mapped? Which actors can contribute to preventive work? What will be expected within precision prevention in the future? Is it possible for public health to shift from reactive to proactive? How could one ensure equitable access to precision prevention tools and prevent exclusion based on socioeconomic status, geography, or ethnicity?
Luncheon
Bus transportation to central Stockholm
About the 15 confirmed speakers
Afzelius, Lovisa, General Partner at Flagship Pioneering. She has co-founded seven companies operating at the intersection of biology and AI, including Alltrna, Apriori Bio, Metaphore Biotechnologies, and Prologue Medicines. Lovisa has served as CEO, co-founder, president, board chairman, and executive director in emerging biotech and large pharma companies. Prior to Flagship, Lovisa held leadership roles at Pfizer and Astra Zeneca for 15+ years, developing drugs, including several on the market in the autoimmunity space. Lovisa has a PhD in computational chemistry from Uppsala University, an MS in integrative pharmacology from Gothenburg University, and an MBA from the MIT Sloan School of Management.
Arrhenius, Gustaf, Director of the Institute for Futures Studies (IFFS) since 2015 and a Professor of Practical Philosophy. He holds a Ph.D. in Philosophy from University of Toronto and a doctorate in Practical Philosophy from Uppsala University. His research focuses on moral and political philosophy, particularly on what we owe to future generations, democratic theory, and fair distribution of power. He has been a visiting researcher at many institutions, such as the University of Oxford and CNRS. He is a member of Academia Europaea and serves on the board of Sweden’s Health and Social Care Analysis Agency and UUniCORN at Uppsala University.
Dahlen, Micael, holds the Chaired Professor in Wellbeing, Welfare and Happiness and is the Center for Wellbeing, Welfare and Happiness (CWWH) director at Stockholm School of Economics. Micael has a particular interest in what constitutes a good life and how truly good economics, in which the actions of and exchanges between individuals, organizations, and society have extended and synergetic effects, can make a good life for all.
Ekblom, Örjan, Professor in Sport Science, deputy head of department of physical activity and health at The Swedish School of Sport and Health Science. Örjan studies how physical activity, sedentary behavior, and fitness impact health through epidemiological and experimental research. He is one of Dagens Nyheter's expert panel, where he answers questions about exercise, physical activity and health.
Jonsdottir, Ingibjörg, Professor at the School of Public Health and Community Medicine at the Sahlgrenska Academy, Gothenburg University and a director for the Institute of Stress Medicine (ISM). ISM is a research institute located in the western part of Sweden that works with different aspects of work-related stress, including clinical research and research on organizational and social work environments. Ingibjörg is involved in projects related to clinical research focusing on individuals with burnout/exhaustion, as well as research focusing on organizational and social work environments.
Larsson, Stefan, Advisor in Healthcare and Life Sciences at International Consortium for Health Outcomes Measurement (ICHOM)
Lindgren, Peter, Managing director of The Swedish Institute for Health Economics and is a professor of health economics at Karolinska Institutet. Peter has over 20 years of experience in Swedish and international health economic studies across various fields, with nearly 100 scientific publications, and has held leading roles in consulting and R&D activities. Since finishing his PhD on the economics of cardiovascular prevention, the area of prevention has always been close to his heart.
Nihlén Fahlqvist, Jessica, Associate Professor in Practical Philosophy and a Senior Lecturer in Biomedical Ethics at the Centre for Research Ethics and Bioethics. She holds a PhD in Philosophy from the Royal Institute of Technology and has conducted postdoctoral research at Delft University of Technology. Her work focuses on moral responsibility, public health, and technology. She also teaches ethics in medical and biotechnology programs and leads master's courses in public health ethics.
Olausson Mats, SEB, Senior Advisor, Climate & Sustainable Finance, Sustainable Banking, SEB. His primary responsibilities include tailored advisory on green and social bonds, sustainability linked loans and bonds as well as other sustainable finance opportunities such as Health Impact Bonds to issuers, investors and other stakeholders. Mats has provided structural advice to over 80 clients in developing frameworks for sustainable finance solutions within various sectors and regions. Prior to joining SEB, he worked for UNDP in Bolivia and at SIDA. Mats has a Bachelor of Social Science with a major in Economics (coupled with Development Studies and Spanish) from the Stockholm University.
Orring, Emilie, Group leader for Moderaterna (Moderate Party) since January 2020 and second vice chairman of the Regional Board in Uppsala. She served as Chair of the Regional Executive Board in Region Uppsala from January 2020 to February 2024, becoming the first woman in this position. After a new administration was formed without the Moderates, she became the second vice chair of the Regional Executive Board and an opposition councillor. She studied at Uppsala and Lund University, earning a Bachelor of Political Science and a Bachelor of Economics in Commercial Law. She has previously worked as a political secretary in Uppsala Municipality and at the Swedish Migration Agency.
Petrovski, Slavé, Human geneticist by training with over 15 years’ experience leading large-scale omics studies. In this time, Slavé has contributed to shaping the field of contemporary population and statistical genomics, including introducing machine learning & advanced analytics to identify numerous drug targets across a diverse range of diseases. Since 2017, as the Vice President and Head of AstraZeneca’s Centre for Genomics Research (CGR) Slavé is accountable for architecting and delivering the company’s Genomics Initiative strategy. He has built in-house capabilities and expertise across key domains: Bioinformatics, Statistical Genetics, Innovative AI/ML methods, multi-omics, and clinical sciences. Applying these cross-disciplinary skills to large-scale omics datasets.
Stanworth, Neil, Founding Director of ATQ Consultants, specializing in outcome-based commissioning including social outcomes contracts (SOCs) and social impact bonds (SIBs). He has worked extensively with commissioners and providers to develop SOCs, SIBs and other innovative contracts. He is also an experienced researcher and evaluator of SOCs and SIBs for the UK government and is leading the evaluation of the Commissioning Better Outcomes Fund (CBO) in partnership with Ecorys UK. Neil is a former fellow of practice at the Government Outcomes Lab (GO Lab), part of Oxford University, and contributes regularly to GO Lab guidance and events.
Stenfors, Cecilia, Associate Professor, researcher, and university lecturer at the Department of Psychology, Stockholm University, where she leads the Stenfors Lab. Her research focuses on the interplay between human, environmental, and planetary health and sustainability. Studies explore the interconnection between our environments and human health, cognition and well-being. She leads projects examining how different natural and urban environment exposures, as well as work-life factors, affect health and wellbeing — both before and during the Covid-19 pandemic.
Sundberg, Carl Johan, Professor at the Department of Physiology and Pharmacology at Karolinska Institutet and Dean for Karolinska Institutet Campus North. His research focuses on the effects and role of physical activity in the prevention and treatment of disease. He is elected to the Royal Swedish Academy of Engineering Sciences and has been a member or chairman of numerous academic and industry boards.
Trolle Lagerros, Ylva, Holds the Prince Daniel Professorship in Cardiovascular Prevention at Karolinska Institutet. She is a specialist in internal medicine with a focus on obesity. Her research spans from how lifestyle habits influence the risk of cardiovascular disease to clinical studies and intervention studies aimed at implementing and maintaining healthy lifestyle habits in at-risk groups.
Stockholm Science City Foundation is arranging the symposium in collaboration with Nordstjernan.
